New eye drops aim to tame uveitis without steroids
Disease control
Recruiting now
This study tests NOV05, a water-free tacrolimus eye drop, in 20 adults with active non-infectious anterior uveitis. Participants receive either a high or low dose for 6 weeks. The goal is to see if it safely controls inflammation and reduces the need for steroid eye drops.
Phase: PHASE2 • Sponsor: Novaliq GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC